Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

Wolters Kluwer Webinar Brings Together Nursing Leaders to Discuss New Technologies

Across industries, the influx of new technology is continuing to roll out at a break-neck pace, with artificial intelligence (AI) at the forefront. To examine the opportunities and risks in using new technologies for research, evidence based practice (EBP) and quality improvement (QI) Wolters Kluwer Health, will host an online event titled, “Achieving academic excellence in nursing with new technologies: An Ovid® Synthesis webinar,” on Tuesday, June 13th from 2 to 3pm ET.

“In the midst of rapid adoption of AI-based technologies globally, a range of concerns ranging from academic integrity to plagiarism to misinformation has heightened the awareness among educators surrounding a need for action,” said Vikram Savkar, Senior Vice President & General Manager, Medicine Segment, Health Learning, Research & Practice at Wolters Kluwer Health. “The academic landscape must examine the best ways to benefit from these technologies while understanding the risks that may come with the implementation.”

The issues facing faculty and nursing students when it comes to using new technologies can seem overwhelming, so it is especially important to understand how generative AI could be used in developing research, EBP, and QI projects. In addition to the conversation around AI, the expert group will highlight how Ovid Synthesis can support a learning environment that promotes independent critical thinking and academic integrity.

The distinguished group of panelists that will discuss the oversight, guidance and support needed for academia facing this inflection point, includes:

  • Marilyn H. Oermann, PhD, RN, ANEF, FAAN, Thelma M. Ingles Professor of Nursing, Duke University School of Nursing; Editor-in-Chief, Nurse Educator
  • Grace H. Sun, MSN, NP, Associate Professor, Texas Tech University Health Sciences Center
  • Stephanie H. Hoelscher, DNP, RN-BC, CPHIMS, CHISP, FHIMSS, Associate Professor of Graduate Informatics and an Informatics Nurse Specialist, Texas Tech University Health Sciences Center
  • Shea Polancich, PhD, RN, Associate Professor and Assistant Dean, University of Alabama at Birmingham School of Nursing
  • (Host) Rachel Dicker, Product Management Associate Director, Wolters Kluwer, Health Learning, Research & Practice

Working in tandem with other groundbreaking technologies, Ovid Synthesis serves as a research repository, allowing all project information to be organized and stored in one simple solution, eliminating breakdowns and stalled projects. Learn more about how Ovid Synthesis can support your organization’s academic research challenges.

Wolters Kluwer Health provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy